Requirements for nitric oxide production by turbot (Scophthalmus maximus) head kidney macrophages.
The effect of different cytokines and bacterial lipopolysaccharide (LPS) on turbot (Scophthalmus maximus) macrophage nitric oxide (NO) production has been studied. We have found two different responses concerning NO production in response to LPS. We have studied 43 turbot and only macrophage cultures derived from 30.2% of these turbot were significantly stimulated by LPS. The macrophage populations that did not respond to LPS, showed a constitutive production that was significantly reversed by NO inhibitors like N(G)-methyl-L-arginine (L-NMMA) and N-omega-nitro-L-arginine (L-NAME), and was dependent on intracellular calcium concentration. We studied the effect of other stimuli combined with LPS on the NO production of these otherwise non-responsive macrophages. LPS combined with turbot macrophage activating factor (MAF) containing supernatants, was capable of significantly stimulating some of these macrophage populations. The same response was observed when LPS was combined with turbot IFN-alphabeta-like substances. When LPS was combined with human recombinant tumor necrosis factor alpha (hrTNF-alpha), the NO production was significantly induced in all macrophage populations studied.
Tafalla
C
C
Instituto de Investigaciones Marinas, CSIC, Eduardo Cabello, 6, 36208, Vigo, Spain.
Novoa
B
B
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005412:Flatfishes / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D016899:Interferon-beta / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D007668:Kidney / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000276:immunology; D016215:Macrophage-Activating Factors / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000201:enzymology / Q000276:immunology / Q000378:metabolism*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D019323:omega-N-Methylarginine / Q000494:pharmacology
D004791:Enzyme Inhibitors; D016898:Interferon-alpha; D007476:Ionophores; D008070:Lipopolysaccharides; D016215:Macrophage-Activating Factors; D014409:Tumor Necrosis Factor-alpha; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D000001:Calcimycin; D016899:Interferon-beta; D019331:NG-Nitroarginine Methyl Ester